P2X7 in Cancer: From Molecular Mechanisms to Therapeutics

Area of Science:

• Immunology
• Cell Biology
• Oncology

Background:

• P2X7 receptor (P2X7) is a transmembrane receptor involved in pain and immune responses.
• Extracellular ATP activates P2X7, leading to cation influx and, upon prolonged activation, macropore formation and cell death.
• P2X7 is upregulated in many cancers and plays a role in tumor development and metastasis.

Purpose of the Study:

• To review recent advances in understanding P2X7 structure and function in cancer progression.
• To explore how P2X7 modifications impact its role in cancer.
• To summarize potential therapeutic strategies targeting P2X7 in cancer therapy.

Main Methods:

• Literature review of P2X7 receptor function in cancer.
• Analysis of P2X7 splice variants, SNPs, and post-translational modifications.
• Examination of preclinical cancer models using P2X7 agonists and antagonists.

Main Results:

• P2X7 activation can promote cancer cell survival and metastasis.
• High ATP levels in the tumor microenvironment can paradoxically challenge cancer cell survival via P2X7.
• Receptor modifications (splice variants, SNPs, PTMs) can impair P2X7 macropore formation, protecting cancer cells.
• P2X7 agonists and antagonists show promise in preclinical cancer models.

Conclusions:

• P2X7 has complex roles in cancer, promoting progression but also presenting a vulnerability.
• Targeting P2X7 function, particularly macropore formation, offers a potential therapeutic avenue.
• Further research into P2X7 regulation and targeted therapies is warranted for innovative cancer treatment.